Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies

This report presents a case of a neurofascin-155 (NF155)+ autoimmune nodopathy (AN) patient who exhibited resistance to conventional treatments but responded positively to telitacicept therapy. Telitacicept, a dual inhibitor of B lymphocyte stimulator (BLyS) and A proliferation-inducing ligand (APRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yijun, Chen, Si, Yang, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642300/
https://www.ncbi.nlm.nih.gov/pubmed/37965304
http://dx.doi.org/10.3389/fimmu.2023.1279808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642300/
https://www.ncbi.nlm.nih.gov/pubmed/37965304
http://dx.doi.org/10.3389/fimmu.2023.1279808

Ejemplares similares